Catalyst Wire Dossier Catalyst Wire Dossier

Interferon-α2b (high dose)

Interferon-alpha-2b
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Interferon-α2b (high dose), covering 2018-02-09 to 2018-02-09. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Study of KW2871 Combined With High Dose Interferon-α2b in Patients With Metastatic Melanoma [Phase 2]

See pricing